IP Library Granted Patent US 10,065,038
Granted Patent B2
US 10,065,038 · App. 15/639,300 · Granted Sep 4, 2018

System and method for treating obstructive sleep apnea

Inventor: Francis A. Papay (Westlake, OH)
Assignee: The Cleveland Clinic Foundation
A61N1/3611A61F2/2803A61N1/0452A61N1/0456A61N1/0551A61N1/3601A61N1/36135A61N1/3787A61F2002/2807
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,065,038
App. No.
15/639,300
Granted
Sep 4, 2018
Kind
B2
Abstract

One aspect of the present disclosure relates to a system for treating obstructive sleep apnea in a subject. The system can include a power source and a neuromuscular stimulator in electrical communications with the power source. The neuromuscular stimulator can include a controller and at least one electrode. The controller can be configured to receive certain power and stimulation parameters associated with a therapy signal from the power source. The at least one electrode can be configured to deliver the therapy signal to a target tissue associated with control of a posterior base of the tongue of the subject.

Claims (19)

1. A method for treating disordered breathing that occurs during sleep in a subject, the method comprising:

obtaining a neurostimulator comprising an electrode;

implanting at least a portion of the neurostimulator in the subject's mandible;

positioning the electrode in electrical communication with an anterior lingual muscle or a nerve that innervates an anterior lingual muscle; and

activating the neurostimulator to deliver an electrical signal to the anterior lingual muscle or the nerve to open an oropharyngeal airway.

2. The method of claim 1 , wherein the anterior lingual muscle is a genioglossus muscle, an anterior belly digastric muscle, a hyoglossus muscle, a mylohyoid muscle, or a combination thereof.

3. The method of claim 1 , wherein the nerve is a hypoglossal nerve, a distal arborizing branch of a hypoglossal nerve at or near its neuromuscular junction, or a combination thereof.

4. The method of claim 1 , wherein the neurostimulator includes a first electrical lead and a second electrical lead, each of which includes an electrode connected thereto.

5. The method of claim 4 , further comprising:

forming a first hole through the mandible on a first side of a midline of the subject;

forming a second hole through the mandible on a second opposing side of the midline of the subject;

inserting the first and second electrical leads through the first and second holes, respectively, so that the electrode of each of the first and second electrical leads is in electrical communication with the nerve or the anterior lingual muscle.

6. The method of claim 1 , wherein activating the neurostimulator to deliver an electrical signal to the anterior lingual muscle or the nerve causes a posterior base of a tongue of the subject to be displaced in an anterior direction or causes a change in a surface morphology of the posterior base of the tongue to allow and increase oropharyngeal airway volume.

7. The method of claim 1 , wherein a trans-mandibular surgical approach is used to implant the neurostimulator.

8. The method of claim 7 , wherein the trans-mandibular surgical approach is a submental approach.

9. The method of claim 8 , wherein implanting at least a portion of the neurostimulator in the subject's mandible comprises:

forming a sulcus in the anterior mandible; and

securing the neurostimulator in the sulcus so that the electrode is in electrical communication with the anterior lingual muscle or the nerve.

10. The method of claim 7 , wherein the trans-mandibular surgical approach is an intraoral bucca-gingival sulcus approach.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 29, 2024
From: PAPAY, FRANCIS A.
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 066607/0484 →
Continuity (5)
Continuation 15341039 · Nov 2, 2016
Division 14547400 · Nov 19, 2014
Provisional Application 61905989 · Nov 19, 2013
Provisional Application 61994149 · May 16, 2014
Related Publication 20170296815A1 · Oct 19, 2017
Cited By (9)
US 12,201,832 US 12,415,075 US 12,434,058 US 12,491,366 US 12,582,822 US 12,589,246 US 12,599,335 US 12,623,078 US 12,636,497